Sign in Subscribe
Cancer

Gastric Cancer Research Uncovers Key Biomarkers and Molecular Mechanisms

Strategic Insights

— 2 min read

New research published in Biochemistry and Biophysics Reports reveals significant findings on gastric cancer, including the identification of THY1 as a prognostic marker and the elucidation of its transcriptional regulation as a component of the epithelial-mesenchymal transition. The study, led by researchers at the Instituto Nacional de Cancer (INCA), found that high expression of THY1 is associated with aggressive tumor behavior and poor patient outcomes in gastric cancer. Furthermore, the research identified six putative transcription factors that regulate THY1 expression and are involved in key processes associated with tumor invasion and metastasis.

Key Takeaways:

  • Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, with high molecular heterogeneity contributing to its poor prognosis.
  • THY1 is a prognostic marker associated with aggressive tumor behavior and poor patient outcomes in gastric cancer.
  • The transcriptional mechanisms governing THY1 expression in gastric cancer remain largely unexplored, but research has identified six putative transcription factors (PRRX1, TWIST1, SNAI2, MEIS3, VENTX, and EGR2) as robust regulators of THY1.
  • The researchers used chromatin immunoprecipitation (ChIP) assays to demonstrate the direct and differential binding of TWIST1 and SNAI2 to the THY1 promoter, supporting their roles as key regulators of THY1 expression in gastric cancer.
  • The study provides a mechanistic link between THY1 expression and epithelial-mesenchymal transition (EMT) transcriptional programs, offering insights into its association with a poor prognosis.
  • The findings contribute to a broader understanding of gastric cancer progression and may inform future therapeutic strategies targeting EMT-related pathways in THY1high gastric cancer.
  • Researchers used multicohort transcriptomic data (n = 945) to infer consensus transcriptional regulatory networks (TRNs) and identified six putative transcription factors as robust regulators of THY1.

Statistics:

  • Gastric cancer is one of the leading causes of cancer-related mortality worldwide (Biochemistry and Biophysics Reports, 2025).
  • High expression of THY1 is associated with aggressive tumor behavior and poor patient outcomes in gastric cancer (Biochemistry and Biophysics Reports, 2025).
  • The study integrated bioinformatic predictions with experimental demonstration, analyzing multicohort transcriptomic data (n = 945) (Biochemistry and Biophysics Reports, 2025).
  • The researchers identified six putative transcription factors as robust regulators of THY1, including PRRX1, TWIST1, SNAI2, MEIS3, VENTX, and EGR2 (Biochemistry and Biophysics Reports, 2025).

Sources:

  • Instituto Nacional de Cancer (INCA). Researchers Illuminate Research in Gastric Cancer (High expression of THY1 is a prognostic marker for gastric Cancer: Deciphering its transcriptional regulation as a component of the Epithelial-mesenchymal ...). Cancer Weekly. June 10, 2025; p 977.
  • Biochemistry and Biophysics Reports. High expression of THY1 is a prognostic marker for gastric Cancer: Deciphering its transcriptional regulation as a component of the Epithelial-mesenchymal transition. 2025, 42(): 102050. (http://www.journals.elsevier.com/biochemistry-and-biophysics-reports/).

Note: Since the original text did not provide a specific date for the journal article, I maintained the original publication date mentioned in the news report.

Read more